weeks (z = 10.5, p = .03), indicating decreased depressive
symptoms at completion of IPSRT-G were maintained at 12
weeks. At 2 weeks, half (3/6) of the participants had a 50%
reduction in IDS-C scores and 33% (2/6) met remission criteria
(IDS-C score 12).